Mastodon

Dysmenorm® (Tablets) Instructions for Use

Marketing Authorization Holder

Deutsche Homoeopathie Union-Arzneimittel GmbH & Co. KG (Germany)

Contact Information

Deutsche Homoeopathie Union (Germany)

ATC Code

G02C (Other drugs used in gynecology)

Dosage Form

Bottle OTC Icon Dysmenorm® Homeopathic tablets: 80 pcs.

Dosage Form, Packaging, and Composition

Homeopathic tablets white or almost white, sometimes with distinct inclusions, flat-cylindrical, with a bevel, with a light aromatic odor.

1 tab.
Agnus castus (dry residue 1 mg) 125 mg
Pulsatilla pratensis D3 25 mg
Rosmarinus officinalis D2 25 mg
Apis mellifica D3 25 mg

Excipients : lactose monohydrate, magnesium stearate, wheat starch.

80 pcs. – dark glass bottles (1) – cardboard packs.

Clinical-Pharmacological Group

Homeopathic preparation used for menstrual cycle disorders, mastopathy and premenstrual syndrome

Pharmacotherapeutic Group

Homeopathic agent

Pharmacological Action

Homeopathic preparation used for functional menstrual cycle disorders.

Pharmacokinetics

The pharmacokinetics of the drug Dysmenorm® have not been studied.

Indications

  • Functional menstrual cycle disorders (as part of complex therapy).

ICD codes

ICD-10 code Indication
N94.5 Secondary dysmenorrhea
ICD-11 code Indication
GA34.3 Dysmenorrhea

Dosage Regimen

The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen.

Take 1-2 tablets three times daily for a long-term period to achieve the desired therapeutic effect.

Administer the tablets by slowly dissolving them in the mouth, ensuring this is done either 30 minutes before or 30 minutes after a meal to optimize absorption.

Adverse Reactions

No adverse effects have been identified when using the preparation according to the approved indications and at the recommended doses.

Monitor for any unexpected symptoms and discontinue use immediately, consulting a healthcare professional if any occur.

Contraindications

  • Do not use in patients with established hypersensitivity to bee venom or any of the product’s components.
  • Contraindicated during pregnancy due to potential risks.
  • Avoid use in individuals with known allergies to the excipients, including lactose monohydrate or wheat starch.

Use in Pregnancy and Lactation

The drug is contraindicated for use during pregnancy. The use of the drug Dysmenorm® during lactation (breastfeeding) is possible only if the intended benefit to the mother outweighs the potential risk to the child.

Special Precautions

When using Dysmenorm®, a temporary worsening of the condition is possible. In this case, the patient should stop taking the drug and consult a doctor.

Overdose

No cases of overdose have been reported to date; however, in the event of suspected excessive intake, discontinue use immediately.

Provide symptomatic and supportive care as no specific antidote exists; consult a poison control center or physician for management guidance.

Drug Interactions

No specific drug interactions with other medicinal products have been established based on available data.

Exercise caution and monitor for any changes in therapeutic effect when co-administering with other medications, and inform your doctor about all concurrent drug use.

Storage Conditions

The drug should be stored in a dry place, out of the reach of children, at a temperature between 15°C (59°F) and 25°C (77°F).

Shelf Life

Shelf life – 5 years.

Dispensing Status

The drug is approved for use as an over-the-counter product.

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.

Medical Disclaimer

TABLE OF CONTENTS